SARS-CoV-2 Omicron Variant Neutralization after mRNA-1273 Booster Vaccination

Detalles Bibliográficos
Autores principales: Pajon, Rolando, Doria-Rose, Nicole A., Shen, Xiaoying, Schmidt, Stephen D., O’Dell, Sijy, McDanal, Charlene, Feng, Wenhong, Tong, Jin, Eaton, Amanda, Maglinao, Maha, Tang, Haili, Manning, Kelly E., Edara, Venkata-Viswanadh, Lai, Lilin, Ellis, Madison, Moore, Kathryn M., Floyd, Katharine, Foster, Stephanie L., Posavad, Christine M., Atmar, Robert L., Lyke, Kirsten E., Zhou, Tongqing, Wang, Lingshu, Zhang, Yi, Gaudinski, Martin R., Black, Walker P., Gordon, Ingelise, Guech, Mercy, Ledgerwood, Julie E., Misasi, John N., Widge, Alicia, Sullivan, Nancy J., Roberts, Paul C., Beigel, John H., Korber, Bette, Baden, Lindsey R., El Sahly, Hana, Chalkias, Spyros, Zhou, Honghong, Feng, Jing, Girard, Bethany, Das, Rituparna, Aunins, Anne, Edwards, Darin K., Suthar, Mehul S., Mascola, John R., Montefiori, David C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Massachusetts Medical Society 2022
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8809504/
https://www.ncbi.nlm.nih.gov/pubmed/35081298
http://dx.doi.org/10.1056/NEJMc2119912

Ejemplares similares

Ejemplares similares